Yes, triglyceride levels increase during infection
Triglycerides consistently rise during acute infections, with plasma levels increasing up to four-fold in septic patients, making hypertriglyceridemia a hallmark metabolic response to infection 1.
Mechanisms of Triglyceride Elevation
The increase in triglycerides during infection occurs through multiple pathways:
- Low-dose infection/endotoxin exposure: Stimulates hepatic triglyceride production through increased de novo fatty acid synthesis and peripheral lipolysis 2
- High-dose/severe infection: Impairs triglyceride clearance by reducing lipoprotein lipase activity and apolipoprotein E in VLDL 1, 2
- VLDL accumulation: All sizes of VLDL particles increase during infection, particularly in severe cases 3
The severity matters algorithmically: mild infections primarily increase hepatic production, while severe sepsis adds impaired clearance, resulting in more pronounced hypertriglyceridemia 2.
Clinical Evidence Across Infection Types
This phenomenon is remarkably consistent across different pathogens:
- Bacterial infections: Septic patients show plasma triglycerides and free fatty acids increasing up to four-fold 1
- Viral infections: Infectious mononucleosis causes transient hypertriglyceridemia in 53.9% of patients (median 156 mg/dL vs 76 mg/dL in controls), with levels normalizing during convalescence 4
- Parasitic infections: Trypanosoma infection produces marked hypertriglyceridemia through defective triglyceride degradation 5
- Chronic infections: H. pylori seropositivity correlates with elevated triglycerides, particularly in females 6
Association with Inflammation and Severity
The triglyceride elevation directly correlates with:
- Inflammatory markers (CRP, IL-6, IL-12) 3
- Lipopolysaccharide (LPS) levels (r = 0.654, P < 0.001) 3
- White blood cell counts and liver damage markers 4
- Disease severity in sepsis 1, 7
Importantly, low HDL cholesterol accompanies the triglyceride rise and inversely correlates with sepsis severity 7.
Critical Pitfall: Toxic Accumulation
The most important clinical caveat: while triglyceride elevation may initially serve a protective role by binding and neutralizing bacterial endotoxins 7, inflammation simultaneously down-regulates fatty acid oxidation enzymes, leading to toxic accumulation of free fatty acids in organs, causing severe organ damage and interfering with mitochondrial function 1. This creates a dangerous metabolic trap where lipids accumulate but cannot be utilized.
Time Course
The hypertriglyceridemia is typically transient, occurring rapidly (within 2 hours of endotoxin exposure) 2 and resolving during convalescence. In infectious mononucleosis, 83.7% of patients showed decreased triglycerides during recovery 4.